Gilead
About Gilead
About Gilead
At Gilead, we are dedicated to advancing the care of patients suffering from life-threatening diseases worldwide.

Gilead 2010 Annual Report

  Read the Gilead Sciences 2010 Annual Report

Advancing Therapeutics, Improving Lives

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need.

In just over 20 years, Gilead has become a leading biopharmaceutical company with a portfolio of 14 marketed products, a growing pipeline of investigational drugs and approximately 4,500 employees in offices across four continents.

Gilead’s primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular/metabolic and respiratory conditions.

To begin learning more about Gilead Sciences, view Gilead-at-a-Glance.